What is Indivior Pharmaceuticals, Inc. Common Stock's Market Cap?

Indivior Pharmaceuticals, Inc. Common Stock's Market Cap is $4.0B, based on as-reported figures from SEC (XBRL) filings.

What is Indivior Pharmaceuticals, Inc. Common Stock's Enterprise Value?

Indivior Pharmaceuticals, Inc. Common Stock's Enterprise Value is $4.3B, based on as-reported figures from SEC (XBRL) filings.

What is Indivior Pharmaceuticals, Inc. Common Stock's Trailing P/E?

Indivior Pharmaceuticals, Inc. Common Stock's Trailing P/E is 11.3×, based on as-reported figures from SEC (XBRL) filings.

What is Indivior Pharmaceuticals, Inc. Common Stock's Price / Sales?

Indivior Pharmaceuticals, Inc. Common Stock's Price / Sales is 3.0×, based on as-reported figures from SEC (XBRL) filings.

What is Indivior Pharmaceuticals, Inc. Common Stock's EV / Revenue?

Indivior Pharmaceuticals, Inc. Common Stock's EV / Revenue is 3.2×, based on as-reported figures from SEC (XBRL) filings.

What is Indivior Pharmaceuticals, Inc. Common Stock's EV / EBITDA?

Indivior Pharmaceuticals, Inc. Common Stock's EV / EBITDA is 10.0×, based on as-reported figures from SEC (XBRL) filings.

What is Indivior Pharmaceuticals, Inc. Common Stock's Revenue (TTM)?

Indivior Pharmaceuticals, Inc. Common Stock's Revenue (TTM) is $1.3B, based on as-reported figures from SEC (XBRL) filings.

What is Indivior Pharmaceuticals, Inc. Common Stock's Net Income (TTM)?

Indivior Pharmaceuticals, Inc. Common Stock's Net Income (TTM) is $356.0M, based on as-reported figures from SEC (XBRL) filings.

What is Indivior Pharmaceuticals, Inc. Common Stock's EBITDA?

Indivior Pharmaceuticals, Inc. Common Stock's EBITDA is $430.0M, based on as-reported figures from SEC (XBRL) filings.

What is Indivior Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM)?

Indivior Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM) is 3.02, based on as-reported figures from SEC (XBRL) filings.

Indivior Pharmaceuticals, Inc. Common Stock (INDV) Financial Statements

Indivior Pharmaceuticals, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG01ZTXFLX8

XNAS · usd

34.13▼ 0.20 (-0.57%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close34.32

Day's Range33.84 – 34.84

52-Week Range22.22 – 42.81

Volume1.8M

Avg Volume2.3M

Share Statistics

Shares Outstanding

Employees838

ExchangeXNAS

Listed2014-12-24

Share count as of July 28, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Indivior Pharmaceuticals, Inc. Common Stock (INDV)

What is Indivior Pharmaceuticals, Inc. Common Stock's Market Cap?: Indivior Pharmaceuticals, Inc. Common Stock's Market Cap is $4.0B, based on as-reported figures from SEC (XBRL) filings.
What is Indivior Pharmaceuticals, Inc. Common Stock's Enterprise Value?: Indivior Pharmaceuticals, Inc. Common Stock's Enterprise Value is $4.3B, based on as-reported figures from SEC (XBRL) filings.
What is Indivior Pharmaceuticals, Inc. Common Stock's Trailing P/E?: Indivior Pharmaceuticals, Inc. Common Stock's Trailing P/E is 11.3×, based on as-reported figures from SEC (XBRL) filings.
What is Indivior Pharmaceuticals, Inc. Common Stock's Price / Sales?: Indivior Pharmaceuticals, Inc. Common Stock's Price / Sales is 3.0×, based on as-reported figures from SEC (XBRL) filings.
What is Indivior Pharmaceuticals, Inc. Common Stock's EV / Revenue?: Indivior Pharmaceuticals, Inc. Common Stock's EV / Revenue is 3.2×, based on as-reported figures from SEC (XBRL) filings.
What is Indivior Pharmaceuticals, Inc. Common Stock's EV / EBITDA?: Indivior Pharmaceuticals, Inc. Common Stock's EV / EBITDA is 10.0×, based on as-reported figures from SEC (XBRL) filings.
What is Indivior Pharmaceuticals, Inc. Common Stock's Revenue (TTM)?: Indivior Pharmaceuticals, Inc. Common Stock's Revenue (TTM) is $1.3B, based on as-reported figures from SEC (XBRL) filings.
What is Indivior Pharmaceuticals, Inc. Common Stock's Net Income (TTM)?: Indivior Pharmaceuticals, Inc. Common Stock's Net Income (TTM) is $356.0M, based on as-reported figures from SEC (XBRL) filings.
What is Indivior Pharmaceuticals, Inc. Common Stock's EBITDA?: Indivior Pharmaceuticals, Inc. Common Stock's EBITDA is $430.0M, based on as-reported figures from SEC (XBRL) filings.
What is Indivior Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM)?: Indivior Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM) is 3.02, based on as-reported figures from SEC (XBRL) filings.